Edwards Carladenise Armbrister has filed 5 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 67160 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE ($CLOV) on May 18, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Edwards Carladenise Armbrister | Director | S | Class A Common Stock | 67160 | $3.42 | 285,432.0000 | 512,743,521 | 19.05% | 0.01% |
| Jan. 6, 2026 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Edwards Carladenise Armbrister | Director | A | Class A Common Stock | 79365 | $0.00 | 352,592.0000 | 512,743,521 | 29.05% | 0.02% |
| March 7, 2025 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Edwards Carladenise Armbrister | Director | S | Class A Common Stock | 200000 | $3.61 | 273,227.0000 | 490,018,730 | 42.26% | 0.04% |
| Jan. 6, 2025 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Edwards Carladenise Armbrister | Director | A | Class A Common Stock | 60975 | $0.00 | 473,227.0000 | 490,018,730 | 14.79% | 0.01% |
| Jan. 3, 2024 | CLOVER HEALTH INVESTMENTS, CORP. /DE | $CLOV | Edwards Carladenise Armbrister | Director | A | Class A Common Stock | 206185 | $0.97 | 412,252.0000 | 482,176,127 | 100.06% | 0.04% |